Related Experiment Video
Updated: Jun 23, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
14.9K
Undifferentiated Pleomorphic Sarcoma: Long-Term Follow-Up from a Large Institution
Shiqi Chen1,2, Wending Huang1,2, Peng Luo1,2
1Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China.
Cancer Management and Research
|December 11, 2019
Summary
Undifferentiated pleomorphic sarcoma (UPS) outcomes are influenced by tumor presentation, size, and involvement of critical structures. Wide surgical margins are crucial for controlling disease recurrence in UPS patients.
Area of Science:
- Oncology
- Surgical Pathology
- Sarcoma Research
Background:
- Undifferentiated pleomorphic sarcoma (UPS) is a challenging soft tissue sarcoma.
- Understanding clinical features and prognostic factors is vital for improving patient outcomes.
Purpose of the Study:
- To delineate the clinical characteristics of undifferentiated pleomorphic sarcoma (UPS).
- To identify independent predictors of poor outcomes in UPS patients.
Main Methods:
- Retrospective review of 100 UPS patients undergoing surgical resection.
- Clinicopathological variables and treatment strategies were analyzed.
- Kaplan-Meier and Cox regression methods were used for survival analysis.
Main Results:
- Median follow-up was 94 months. Key prognostic factors for overall survival (OS) included tumor presentation, size, and involvement of important structures.
- Independent predictors for local recurrence-free survival (LRFS) were age, resection quality, and tumor grade.
- Tumor depth significantly impacted metastasis-free survival (MFS). 5-year OS, LRFS, and MFS rates were 53%, 55%, and 70% respectively.
Conclusions:
- Expert management in specialized sarcoma centers is recommended for primary UPS treatment.
- Achieving wide surgical margins is essential for effective disease recurrence control.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...